论文部分内容阅读
拉米夫定是一种较新的高效、直接抗乙型肝炎病毒的口服药,治疗对象是伴有丙氨酸氨基转移酶升高和病毒活动复制的肝功能代偿的成年慢性乙型肝炎患者[1]。拉米夫定作为新一代核苷类似物的代表,其问世推动了慢性乙型肝炎治疗的进程,为治疗慢性乙型肝炎增添了新的希望,随着拉米夫定
Lamivudine is a relatively new, highly effective, and immediate anti-HBV oral drug for liver function-compensated adult chronic hepatitis B with elevated alanine aminotransferase and viral activity Patient [1]. Lamivudine as a new generation of nucleoside analogues, the advent of promoting the treatment of chronic hepatitis B, adding new hope for the treatment of chronic hepatitis B, with lamivudine